Guangdong Zhongsheng Pharmaceutical Hits Day High with 10% Surge

Guangdong Zhongsheng Pharmaceutical Co., Ltd. has experienced significant activity today, achieving a notable intraday high of CNY 24.85, reflecting a robust gain of 10.0% on June 29, 2026. This performance stands in stark contrast to the China Shanghai Composite, which only managed a 1.16% increase on the same day. Over the past week, Guangdong Zhongsheng has shown a strong upward trend, with a 12.34% rise compared to a decline of 2.14% in the broader market. The company's performance over the last year has been particularly impressive, with a remarkable 66.44% increase, significantly outpacing the China Shanghai Composite's 18.97% growth. Financially, Guangdong Zhongsheng has reported a substantial increase in net profit, rising by 296.49%, and has consistently delivered positive results for four consecutive quarters. The company boasts a strong operating cash flow of CNY 497.18 million and a return on capital employed (ROCE) of 7.19%. Despite a high price-to-book ratio of 3.79, the stock's performance metrics indicate a solid position within the pharmaceuticals and biotechnology sector.